Understanding the Clinical Utility of Genome Sequencing in Critically Ill Newborns
- 1 July 2023
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 258, 113438
- https://doi.org/10.1016/j.jpeds.2023.113438
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testingGenetics in Medicine, 2020
- Genome Diagnostics: Novel Strategies for Measuring ValueJournal of Managed Care & Specialty Pharmacy, 2019
- Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testingJournal of Genetic Counseling, 2019
- Parents of newborns in the NICU enrolled in genome sequencing research: hopeful, but not naïveGenetics in Medicine, 2019
- Sequencing Newborns: A Call for Nuanced Use of Genomic TechnologiesHastings Center Report, 2018
- The rise of the genome and personalised medicineClinical Medicine, 2017
- Newborn Sequencing in Genomic Medicine and Public HealthPEDIATRICS, 2017
- Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and GenomicsGenetics in Medicine, 2015
- Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findingsThe Lancet Respiratory Medicine, 2015
- The EGAPP initiative: lessons learnedGenetics in Medicine, 2013